PURPOSE: Angiogenesis is needed to sustain growth of both primary and
metastatic lesions; however, comparisons in microvessel density betwee
n a primary tumor and its metastases have not been widely performed. W
e studied microvessel density in primary colorectal cancers and their
liver metastases. METHODS: Sections from 32 primary lesions and 53 hep
atic metastases were immunostained with a monoclonal antibody for von
Willebrand's factor, an endothelial cell marker. Blood vessels were qu
antified under X100 magnification using both conventional light micros
copy and computer-assisted image analysis. Primary and metastatic angi
ogenesis scores (AS), i.e., vessel counts, were analyzed with respect
to tumor size, hepatic multicentricity, synchronicity, resectability,
and patient survival. Using computer-assisted calculations, the same a
nalyses were performed using blood vessel to tumor surface area ratios
, vessel wall thickness, and intensity of immunostaining. RESULTS: Ang
iogenesis scores were significantly lower in metastatic lesions compar
ed with their primary tumors (P < 0.0001). Primary AS did not correlat
e with metastatic tumor size, resectability, multicentricity, or patie
nt survival. Metastatic AS strongly predicted patient survival (P < 0.
0009) but with a negative coefficient, i.e., higher scores were associ
ated with improved survival. Metastatic AS were higher in resectable t
han in nonresectable metastases and in solitary than in multiple metas
tases; however, these trends were not statistically significant. Metac
hronous liver lesions had significantly higher angiogenesis scores tha
n synchronous metastases (P < 0.04). Similar trends were seen using co
mputer-assisted image analysis. CONCLUSIONS: These results indicate th
at in presence of an established metastasis, there is a weak angiogeni
c relationship between a primary tumor and its metastasis. Heterogenei
ty in metastatic lesions cannot be explained solely by studying angiog
enesis in primary tumors. Microvessel, density in a primary tumor may
not be useful as an independent prognostic indicator in late stages of
disease. In such cases, assessment of microvessel density in a metast
atic tumor whenever possible may be an indicator of prognosis.